A double-blind, placebo-controlled Phase III study to assess the efficacy of reMAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma, Protocol No: 111482
Laufzeit: 01.01.2009 - 31.12.2009
imported
Kurzfassung
Protocol No: 111482
